Non-coding RNAs related to angiogenesis in gynecological cancer

N Rahimian, ZS Razavi, F Aslanbeigi… - Gynecologic …, 2021 - Elsevier
Gynecological cancer affects the female reproductive system, including ovarian, uterine,
endometrial, cervical, vulvar, and vaginal tumors. Non-coding RNAs (ncRNAs), and in …

Cyclooxygenase‐2 in gastrointestinal malignancies

GP Nagaraju, BF El‐Rayes - Cancer, 2019 - Wiley Online Library
Cyclooxygenase (COX) is an enzyme complex that plays an important role in the conversion
of arachidonic acid to prostaglandins. Prostaglandins are essential modulators of signal …

[HTML][HTML] Loss of miR-101-3p promotes transmigration of metastatic breast cancer cells through the brain endothelium by inducing COX-2/MMP1 signaling

R Harati, MG Mohammad, A Tlili, RA El-Awady… - Pharmaceuticals, 2020 - mdpi.com
Brain metastases represent one of the incurable end stages in breast cancer (BC).
Developing effective or preventive treatments is hampered by a lack of knowledge on the …

[HTML][HTML] Interplay between cyclooxygenase‑2 and microRNAs in cancer

Z Gong, W Huang, B Wang… - Molecular …, 2021 - spandidos-publications.com
Tumor‑associated inflammation and aberrantly expressed biomarkers have been
demonstrated to play crucial roles in the cancer microenvironment. Cyclooxygenase‑2 (COX …

MicroRNA-101 inhibits angiogenesis via COX-2 in endometrial carcinoma

Y Liu, H Li, C Zhao, H Jia - Molecular and cellular biochemistry, 2018 - Springer
Abnormal angiogenesis is critically involved in tumor progression and metastasis including
endometrial cancer and is regulated by microRNAs such as microRNA-101 (miR-101). We …

[HTML][HTML] MiR-26a and miR-144 inhibit proliferation and metastasis of esophageal squamous cell cancer by inhibiting cyclooxygenase-2

Y Shao, P Li, ST Zhu, JP Yue, XJ Ji, D Ma, L Wang… - Oncotarget, 2016 - ncbi.nlm.nih.gov
The altered expression of miRNAs is involved in carcinogenesis of esophageal squamous
cell carcinoma (ESCC), but whether miRNAs regulate COX-2 expression in ESCC is not …

[HTML][HTML] Diagnostic and prognostic implications of serum miR-101 in osteosarcoma

ZS Yao, C Li, D Liang, XB Jiang, JJ Tang… - Cancer …, 2018 - content.iospress.com
Blood-circulating microRNAs (miRNAs) have been reported to be used as potential
biomarkers in various cancers. MiR-101 has been found to act as a tumor suppressor in …

[HTML][HTML] MicroRNA-124 functions as a tumor suppressor by regulating CDH2 and epithelial-mesenchymal transition in non-small cell lung cancer

T Ma, Y Zhao, K Wei, G Yao, C Pan, B Liu… - Cellular Physiology and …, 2016 - karger.com
Background/Aims: Abnormal expression of microRNA-124 (miR-124) was found in non-
small cell lung cancer (NSCLC). However, the association between miR-124 and CDH2 has …

[HTML][HTML] Combination of tanshinone IIA and cisplatin inhibits esophageal cancer by downregulating NF-κB/COX-2/VEGF pathway

X Liao, Y Gao, J Liu, L Tao, D Wang, D Xie… - Frontiers in …, 2020 - ncbi.nlm.nih.gov
Cisplatin (DDP) represents one of the common drugs used for esophageal squamous cell
carcinoma (ESCC), but side effects associated with DDP and drug resistance lead to the …

miR-195-5p regulates cell proliferation, apoptosis, and invasion of thyroid cancer by targeting telomerase reverse transcriptase

Z Liu, L Zhang, W Chen, F Yuan, Z Yang, S Liu… - …, 2021 - Taylor & Francis
In most human primary cancers, the expression, or telomerase activity, of telomerase
reverse transcriptase (TERT) is detectable. However, the mechanism of TERT activity within …